Komori
General Meetings of Shareholders4564OncoTherapy Science,Inc.Pharmaceuticals

Notice of Convocation of the 2026 Annual General Meeting of Shareholders and Meeting Materials

The election of 5 directors and the appointment of an accounting auditor will be submitted as agenda items for the 25th Annual General Meeting of Shareholders, to be held on 23 June 2026.

Worth reading
39Recurring
Scored from 3 of 4 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (25th)
2026
Jun 23
Date and time22 days from this disclosure to the meeting
Matters for resolution2 items
  1. Election of 5 directors

  2. Election of an accounting auditor

Shareholder Proposal

Not disclosed

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee5 candidates (breakdown between new and outside candidates: Not disclosed)
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (25th)
Date and time10:00 a.m. on Tuesday, 23 June 2026
Matters for resolutionProposal 1: Election of 5 directors, Proposal No. 2: Election of an accounting auditor
Shareholder ProposalNot disclosed
Director nominee5 candidates (breakdown between new and outside candidates: Not disclosed)
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To provide notice of the holding of the Annual General Meeting of Shareholders and the submission of agenda items.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 2026 Annual General Meeting of Shareholders and Meeting Materials | OncoTherapy Science,Inc. (4564) timely disclosure | Komori